Predicting clinical response to costimulation blockade in autoimmunity.
Predicting clinical response to costimulation blockade in autoimmunity.
复制标题
DOI:
10.1093/immadv/ltaa003
复制
发表时间:
2021-01
影响因子:
--
通讯作者:
Walker LSK
中科院分区:
文献类型:
--
作者:
Edner NM;Wang CJ;Petersone L;Walker LSK
Curbing unwanted T cell responses by costimulation blockade has been a recognised immunosuppressive strategy for the last 15 years. However, our understanding of how best to deploy this intervention is still evolving. A key challenge has been the heterogeneity in the clinical response to costimulation blockade, and an inability to predict which individuals are likely to benefit most. Here, we discuss our recent findings based on the use of costimulation blockade in people with type 1 diabetes (T1D) and place them in the context of the current literature. We discuss how profiling follicular helper T cells (Tfh) in pre-treatment blood samples may have value in predicting which individuals are likely to benefit from costimulation blockade drugs such as abatacept.
登录
查看更多内容
影响因子:
7.7
作者:
Leete, Pia;Willcox, Abby;Morgan, Noel G.
通讯作者:
Morgan, Noel G.
影响因子:
27.4
作者:
Sokolove J;Schiff M;Fleischmann R;Weinblatt ME;Connolly SE;Johnsen A;Zhu J;Maldonado MA;Patel S;Robinson WH
通讯作者:
Robinson WH
DOI:
10.1126/science.1202947
发表时间:
2011-04-29
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Qureshi OS;Zheng Y;Nakamura K;Attridge K;Manzotti C;Schmidt EM;Baker J;Jeffery LE;Kaur S;Briggs Z;Hou TZ;Futter CE;Anderson G;Walker LS;Sansom DM
通讯作者:
Sansom DM
影响因子:
7.7
作者:
Orban T;Beam CA;Xu P;Moore K;Jiang Q;Deng J;Muller S;Gottlieb P;Spain L;Peakman M;Type 1 Diabetes TrialNet Abatacept Study Group
通讯作者:
Type 1 Diabetes TrialNet Abatacept Study Group
DOI:
10.1084/jem.190.8.1115
发表时间:
1999-10-18
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Walker LS;Gulbranson-Judge A;Flynn S;Brocker T;Raykundalia C;Goodall M;Förster R;Lipp M;Lane P
通讯作者:
Lane P